Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,235 public trials 1,182 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial)

NCT00136864

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
  • Toronto-Sunnybrook Odette Regional Cancer Centre Toronto, Ontario, Canada
View Trial Details
Completed

FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma

NCT00086333

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Providence Health System, Regional Cancer Program Portland, Oregon, United States
  • Kaiser Permanente Portland, Oregon, United States
View Trial Details
Completed

Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-small Cell Lung Carcinoma

NCT00051571

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Bendheim Cancer Center Greenwich, Connecticut, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Hematology Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
View Trial Details
Completed

Molecular Profiling in Lung Cancer Patients

NCT00191308

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bystra, Poland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Poznan, Poland
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland
View Trial Details
Completed

A Phase III Study of the Efficacy of Taxotere/Aptosyn Versus Taxotere/Placebo in Non-Small Cell Lung Cancer Patients

NCT00085826

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham Hematology Oncology Associates Birmingham, Alabama, United States
  • Birmingham Hematology and Oncology Associates, LLC Birmingham, Alabama, United States
  • Northern Arizona Hematology and Oncology Associates Flagstaff, Arizona, United States
  • Hematology & Oncology Associates Phoenix, Arizona, United States
View all 114 locations
View Trial Details
Completed

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

NCT00046787

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • University of Colorado Health Sciences Center Denver, Colorado, United States
  • Baptist Hospital Regional Cancer Ctr. Knoxville, Tennessee, United States
  • Vanderbilt Clinical Trials Office Nashville, Tennessee, United States
View Trial Details
Completed

Study of XL281 in Adults With Solid Tumors

NCT00451880

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Neoplasms, +40 more
Locations
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions